To find out more about a company click on the company name to see a brief profile.
Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
J&J to Submit Over 10 New Drug Applications by 2017
(Morningstar/Dow Jones Newswires) May 23, 2013 - Johnson & Johnson said its pharmaceutical unit plans to submit more than 10 new product applications by 2017, as the health-care giant hopes to build on the division's turnaround in recent years.
read article 
Panel Backs Merck Insomnia Drug
(Wall Street Journal) May 22, 2013 - A federal advisory panel on Wednesday partly endorsed a proposed sleep drug from Merck, saying the product was effective and acceptably safe at lower starting doses.
read article (paid subscription required)
Key Find for Early Bladder Cancer Treatment
(Lund University [Lund, Sweden]) May 22, 2013 - Aggressive forms of bladder cancer involve the protein PODXL - a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
read press release
Senate Panel Approves Tighter Oversight of Compounding Pharmacies, But Bill is Under Fire
(Washington Post) May 22, 2013 - Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall's deadly meningitis outbreak, saying it does not adequately address health risks.
read article (free registration required)
To Scan or Not to Scan: Largest Study to Date Links Childhood CTs to Increased Cancer Risk
(Time Healthland) May 22, 2013 - CT scans can reveal a remarkable amount of useful medical information, but more studies underscore the need to balance the benefits of that knowledge with the risks of being exposed to the scans' small amounts of radiation.
read article
Intensified, Liposomal Anthracycline-Based Chemo Regimen for Children with Leukemia May Offer High Survival Rates Without Added Heart Toxicity
(ASH) May 23, 2013 - Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity.
read press release
More Patients Than Docs Report Skin Surgery Problems
(Reuters) May 22, 2013 - More than one quarter of people being treated for non-melanoma skin cancer in their doctor's office reported some type of complication after surgery, in a new study.
read article
Heartburn Tied to Throat Cancer
(New York Times/Well blog) May 23, 2013 - Frequent heartburn increases the risk for throat cancer, a new study has found, and over-the-counter antacids may provide protection.
read article
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
(MarketWatch) May 23, 2013 - Celgene International Sarl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.
read article
NICE Finds Advanced Ovarian Cancer Treatment Too Expensive With Not Enough Benefit
(NICE) May 22, 2013 - The National Institute for Health and Care Excellence (NICE) has advised the NHS against funding the drug bevacizumab (Avastin, manufactured by Roche) for advanced ovarian cancer.
read press release
Pfizer to Spin Off Remaining Zoetis Stake
(Fox Business/Dow Jones Newswires) May 22, 2013 - Pfizer Inc. plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. through a voluntary exchange offer with its shareholders.
read article
Amag Investigates Anemia Drug After Report of Death in Switzerland
(Reuters) May 21, 2013 - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity.
read article
Glaxo to Get Up to $200 Million for U.S. Research
(Bloomberg) May 22, 2013 - GlaxoSmithKline Plc, the U.K.'s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an agreement valued at as much as $200 million.
read article
Electronic Health Data Gaining Favor
(Wall Street Journal) May 22, 2013 - More than half of U.S. doctors have switched to electronic health records and are using them to manage patients' basic medical information and prescriptions.
read article (paid subscription required)
Wall Street's A-List Turns Out to Fight Skin Cancer
(New York Times/DealBook blog) May 22, 2013 - Jeffrey Rowbottom, a managing director at Kohlberg Kravis Roberts, was greeting guests Tuesday evening at a charity event at the Sea Grill in Rockefeller Center, when one issued a challenge.
read article (paid subscription required)
The Way We Think About Cancer Must Evolve
(Wired) May 22, 2013 - The longer you live, the more chances for a distorted, pernicious cell to elude the body's defenses and develop into full-blown cancer.
read article
American Cancer Society, Born at a Time When Cancer Was a Lesser Threat, Marks 100 Years
(Washington Post/Associated Press) May 22, 2013 - The American Cancer Society - one of the nation's best known and influential health advocacy groups - is 100 years old this week.
read article (free registration required)
Dallas Philanthropist Lyda Hill Gives $50 Million to M.D. Anderson Cancer Initiative
(Dallas Morning News) May 21, 2013 - Dallas philanthropist Lyda Hill has pledged $50 million to the University of Texas M.D. Anderson Cancer Center, the Houston institution announced Tuesday.
read article
Lehigh Valley Health Network Joins the Moffitt Oncology Network
(Lehigh Valley Health Network) May 21, 2013 - Lehigh Valley Health Network is partnering with Moffitt Cancer Center to enhance cancer care by joining the newly launched Moffitt Oncology Network. Lehigh Valley, based in Allentown, Pa., is the first member of the network outside of Florida.
read press release
Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
(GenomeWeb News) May 22, 2013 - Empire Genomics today announced it has licensed a genomic biomarker from Cornell University for the development of a test to diagnose and determine treatment of patients with neuroendocrine prostate cancer, or NEPC.
read article
Mayo Clinic, Cancer Genetics Form Diagnostics JV
(Genetic Engineering News) May 22, 2013 - Mayo Clinic will join with Cancer Genetics to develop and commercialize cancer diagnostics based on next-generation sequencing through a new joint venture.
read article
Given Imaging Study May Help Approval: Israel Overnight
(Bloomberg) May 22, 2013 - Results from Given Imaging Ltd.'s latest clinical study of a pill-sized camera used to identify colon cancer probably will help the Israeli manufacturer secure U.S. regulatory approval this year, Chief Executive Officer Homi Shamir said.
read article
Two in Three Cancer Patients Are Non-Adherent With Their Medications, According to Kantar Health Research
(Albany Times-Union) May 21, 2013 - Two-thirds of patients who have been diagnosed with leukemia, melanoma or non-small cell lung cancer reported that they engage in at least one type of non-adherent behavior in their medicine use, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health.
read article
Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
(Transgene) May 21, 2013 - Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today announced completion of enrollment in the 120-patient TRAVERSE study.
read corporate press release
Why Stomach Cancer is Declining in the US
(dailyRx News) May 21, 2013 - A type of stomach cancer called intestinal-type noncardia gastric adenocarcinoma (NCGA) is on a steep decline in the US, according to a recent review.
read article